Form D · Pharmaceuticals
Matthias Therapeutics, LLC
Basking Ridge, NJ · CIK 0002104165
Offering snapshot reported Jun 1, 2026 · SEC filing
- Reported sold
- $50K Offering amount: $500K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- May 14, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 1, 2026 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Jan 7, 2026 | Initial | $100,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $5K (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-585732
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| TerraNova Capital Equities, Inc. | 45097 |
Source: Form D, filed Jun 1, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Redling | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
27 Sentinel Drive
Basking Ridge, NJ, 07920
Phone: 2016850842
Basking Ridge, NJ, 07920
Phone: 2016850842